DR. STEPHEN J. FORMAN

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

LIXTE BIOTECHNOLOGY HOLDINGS, INC.

Filing Date Source Excerpt
2021-05-25 Stephen J. Forman, M.D., is an internationally recognized expert in hematologic malignancies and bone marrow transplantation and is a leader in preclinical and clinical cancer research. He is co-editor of Thomas’ Hematopoietic Cell Transplantation, a definitive textbook for clinicians, scientists and health care professionals.
2022-08-26 Stephen J. Forman, M.D., is an internationally recognized expert in hematologic malignancies and bone marrow transplantation and is a leader in preclinical and clinical cancer research.
2023-04-11 Dr. Stephen J. Forman is listed as a director, but there is no indication of software-related technical skills.
2023-10-10 Dr. Forman is the Francis and Kathleen McNamara Distinguished Chair in Hematology and Hematopoietic Cell Transplantation at the City of Hope Comprehensive Cancer Center.

Data sourced from SEC filings. Last updated: 2026-03-05